The company's principal activity is to develop products that integrate advanced microelectronics and molecular biology into a platform technology with broad commercial applications. these products are of use in the fields of biomedical research, genomics, medical diagnostics, genetic testing, drug discovery, forensics, agriculture, environmental testing and potentially the electronics and telecommunications industries. the first application that was developed is an integrated bioassay system, the nanochip molecular biology workstation, comprised of two automated instruments and a consumable cartridge. the nanochip provides a flexible tool for the rapid identification and precision analysis of biological test samples containing charged molecules. sponsored research accounted for 67% of 2001 revenues; Product sales, 20% and contract and grant revenue, 13%.